Therapy and Diagnostics based on Organic BioElectonics
|Linköpings universitet - Institutionen för teknik och naturvetenskap
|Funding from Vinnova
|SEK 25 199 605
|February 2011 - February 2016
Purpose and goal
We have met the (revised) aims. We have demonstrated: multiple cell/tissue release technologies, and opened a new field of bioelectronics using ferroelectric polymers; with the ion pump, the first ever use of an organic electronic therapy in an awake animal; with the pe-probes, a tool to identify cancer stem cells with better efficiency than clinical standards. The probes have already been spun-off, and the drug delivery devices will be spun-off soon.
Results and expected effects
With our successful results in all three project areas, and the ongoing commercialization of pe-probes, we believe that we can already offer the medtech industry a range of new theranostic tools. The ion pump has been a ´harder sell´, but we think we are finally poised to commercialize it as well (especially given some recent results). Finally, with the latest materials, the release surfaces are also significantly closer to clinical use.
Approach and implementation
The project was significantly effected by the loss of AstraZeneca and St. Jude. We were forced to focus much more of our time on re-establishing industry partners than on the research and development we originally planned. The revision at halftime, and establishment of a board helped. However, we still suffered from the lack of industrial end-users in the consortium. Perhaps we would be closer to commercialization if we hadn´t lost our original partners.